The Sanford Guide to Antimicrobial Therapy 2026 (Pocket Edition)

Original price was: $8.31.Current price is: $4.99.

Clothing Size Conversion Chart
Category US EU UK Chest (in) Waist (in) Hips (in)
Men XS 44 34 32-34 26-28 33-35
S 46 36 34-36 28-30 35-37
M 48 38 38-40 32-34 39-41
L 50 40 42-44 36-38 43-45
XL 52 42 46-48 40-42 47-49
Women XS 32 6 31-32 24-25 33-34
S 34 8 33-34 26-27 35-36
M 36 10 35-36 28-29 37-38
L 38-40 12-14 37-39 30-32 39-41
XL 42 16 40-42 33-35 42-44
Youth XS 128 7 26-28 23-24 26-28
S 134 8 28-30 24-25 28-30
M 140 10 30-32 25-26 30-32
L 146 12 32-34 26-27 32-34
XL 152 14 34-36 27-28 34-36
Pants Size Conversion Chart
CategoryUSEUUKWaist (in)Hip (in)Inseam (in)
Men284428283430
304630303631
324832323832
345034344033
365236364234
Women0324243430
2346253530
4368263631
63810273832
84012284032
Shoes Size Conversion Chart
CategoryUSEUUKFoot Length (in)
Men6395.59.25
7406.59.625
8417.510
9428.510.25
10439.510.625
114410.511
124511.511.25
134612.511.625
Women5352.58.5
6363.58.875
7374.59.25
8385.59.625
9396.510
10407.510.25
11418.510.625
12429.511
M (Unisex)5374.58.75
6385.59
7396.59.5
8407.510
9418.510.25
10429.510.625
114310.511
124411.511.25
70 People watching this product now!
Description

The 2026 version of the Sanford Guide (56th Edition) helps you make the best infectious diseases treatment decisions, fast. Designed to be an invaluable resource for clinicians involved with ID in any care setting.

The 2025-2026 respiratory virus season remains dominated by the triple threat posed by COVID-19, RSV and influenza. Measles outbreaks are a continuing concern. Vaccination remains the cornerstone of prevention.

Throughout this edition we have updated treatment recommendations based on recent references and guidelines. Also, we have removed many older references that have been superseded or are simply no longer necessary.

Major updates include:

  • Table 1–major updates to native valve endocarditis, adult arthritis, complicated urinary tract infections and plague, as well as minor updates to regimens and comments throughout
  • Table 3–duration of therapy, is substantially revised
  • Tables 5 and 6–highly resistant bacteria, are substantially revised
  • Table 7–new desensitization protocols and references added
  • Table 10A–gets recently approved anti-infectives
  • Table 12A–pulmonary tuberculosis has a major update
  • Tables 11, 13 and 14–covering fungal, parasitic and viral infections respectively are updated as needed
  • Table 15–prophylaxis for dental procedures and candida and cocci prevention are updated for improved clarity
  • New tables 18A, 18B–cover hepatic impairment dosing and DRESS
  • Drug information tables covering pediatric dosing, pharmacology, enzyme- and transporter-mediated interactions, renal impairment dosing, obesity dosing are updated throughout.